Saturday 18 January 2020 ,
Saturday 18 January 2020 ,
Latest News
  • Deferment of city polls: DU VC, DUCSU gen secy express solidarity with protesting students
  • Australian scientists make breakthrough on preventing spread of dengue fever
  • Bangabandhu BPL final: Rajshahi Royals beat Khulna Tigers by 21 runs
  • Plane tragedy should not overshadow loss of commander: Khamenei
  • EC to reach acceptable solution over city polls, Quader hopes
  • 10 students fall sick during hunger strike at DU
  • Newly-married burned couple dies at DMCH
  • Garment workers demand justice for rape victim
  • 2nd phase Biswa Ijtema begins
15 July, 2019 00:00 00 AM

Hospitalized pneumonia patients often get excess antibiotics

drugs.com
Hospitalized pneumonia patients often get excess antibiotics

Patients hospitalized with pneumonia often receive excess antibiotic therapy, according to a study published online July 9 in the Annals of Internal Medicine.

Valerie M. Vaughn, M.D., from the University of Michigan in Ann Arbor, and colleagues examined predictors and outcomes associated with excess duration of antibiotic treatment using retrospective data from 43 hospitals in the Michigan Hospital Medicine Safety Consortium (6,481 general care medical patients with pneumonia). Excess days were determined by subtracting each patient's expected treatment duration (based on time to clinical stability, pathogen, and pneumonia classification) from the actual duration.

The researchers found that more than two-thirds of patients (67.8 percent) received excess antibiotic therapy, with most of the excess duration accounted for by antibiotics prescribed at discharge (93.2 percent).

Excess treatment was more likely among patients who had respiratory cultures or nonculture diagnostic testing, had a longer stay, received a high-risk antibiotic in the previous 90 days, had community-acquired pneumonia, or did not have a total antibiotic treatment duration documented at discharge.

Lower rates of adverse outcomes, including death, readmission, emergency department visit, or Clostridioides difficile infection, were not associated with excess treatment. However, there was a 5 percent increase in the odds of antibiotic-associated adverse events postdischarge with each excess day of treatment.

"Future interventions should focus on whether reducing excess treatment and improving documentation at discharge improves outcomes," the authors write.

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

Ear, Nose and Throat are anatomically connected. Those who have used eye drops have observed it comes to nose and then to mouth through naso-lacrimal…
Anatomy of an ear infection

Anatomy of an ear infection

Ear infections: All too common Ear infections are extremely common, especially in runny-nosed kids. The latest research indicates that when young children…
All you need to know about tonsillitis

All you need to know about tonsillitis

The tonsils sit at the back of the throat. They are collections of lymphoid tissue that form part of the immune system. Although tonsillitis can be uncomfortable…
How to keep your voice healthy?

How to keep your voice healthy?

Many people use their voices for work purpose that puts them at risk for developing voice problems. For example singers, teachers, doctors, lawyers, nurses,…
Tinnitus overview - causes and diagnosis

Tinnitus overview - causes and diagnosis

Dr.Archana Jhawar, M.S. Tinnitus is not a disease rather an annoying symptom of myriad of conditions, caused by minor changes in the sensitive hearing…
Smell disorders

Smell disorders

How common are smell disorders? Our sense of smell helps us enjoy life. We delight in the aromas of our favorite foods or the fragrance of flowers. Our…
5 Diseases that can lead to blindness

5 Diseases that can lead to blindness

 ELAINE K. HOWLEY Our most dominant sense -- sight -- is a surprisingly fragile thing. There are many ways it can be reduced or lost entirely, and…
Exercises for osteoarthritis

Exercises for osteoarthritis

RUBEN CASTANEDA Osteoarthritis is the most common type of arthritis, affecting 31 million people in the U.S., says Marcy O'Koon, senior director,…
Tea drinkers live longer

Tea drinkers live longer

Drinking tea at least three times a week is linked with a longer and healthier life, according to a study published today in the European Journal of Preventive…
‘Science’ recognises research on gut microbes as one of the biggest scientific breakthroughs

‘Science’ recognises research on gut microbes as one of the biggest scientific breakthroughs

The prestigious journal Science recognised the research achievement of icddr,b and Washington University, USA on microbes to combat malnutrition as one…
FDA approves Fiasp (insulin aspart injection) for the treatment of children with diabetes

FDA approves Fiasp (insulin aspart injection) for the treatment of children with diabetes

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Fiasp (insulin aspart injection) 100 u/mL for use as a new…
FDA approves Caplyta (lumateperone) for the treatment of Schizophrenia in adults

FDA approves Caplyta (lumateperone) for the treatment of Schizophrenia in adults

Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting